Introduction
Studies on transgenic mice expressing autoantibodies have as C57BL/6. In mice carrying the lpr mutation, the defect in Fas-mediated apoptosis makes both antigen-stimulated T demonstrated that interaction with self-antigens can either cells and B cells exposed to soluble self-antigens fail to inactivate or eliminate self-reactive B cells, allowing maindie (12, 14, 19) , and it is thought that these defects cause tenance of self-tolerance (1-3). When challenged with lymphadenopathy due to accumulation of activated T cells membrane-bound autoantigens, self-reactive B cells are and autoantibody production by survival of self-reactive B either rapidly eliminated, presumably by apoptosis, or alter cells (20) . However, the defects of the MRL background the antigen specificity by receptor editing. In contrast, soluble involved in the development of severe autoimmune disease autoantigens can cause functional inactivation (anergy) of in MRL-lpr/lpr mice are not yet understood. self-reactive B cells. Anergized B cells also undergo Fas requires both the adapter protein FADD (also called apoptosis, albeit more slowly than apoptosis of B cells MORT1) and caspase-8 for transmission and execution of the encountered with membrane-bound autoantigens (4) . These apoptotic signal (25) (26) (27) . FADD and caspase-8 are also findings suggest that strong B cell antigen receptor (BCR) essential for apoptosis mediated by other members of the ligation by membrane-bound antigens induces rapid tumor necrosis factor (TNF) receptor family that have a death apoptosis, whereas mild BCR ligation by soluble antigens domain in the cytoplasmic region such as type 1 TNF receptor, causes apoptosis more slowly. BCR-mediated apoptosis has DR4, DR5 and DR6 (27) (28) (29) (30) (31) . To assess whether Fas is involved been demonstrated in vitro in transformed B cell lines, such in BCR-mediated apoptosis of human B lymphoma cells, Lens as WEHI-231 (5, 6) , and in normal mature B cells (7) (8) (9) (10) (11) .
et al. (32) have blocked Fas signaling by expression of a When BCR are extensively ligated, using immobilized anti-Ig dominant interfering mutant of FADD. However, FADD appears antibody, most mature B cells undergo apoptosis within 48 h, to play a role in cell proliferation as well as in apoptotic whereas only a small fraction of mature B cells undergo signals (33, 34) . To circumvent this potential complication, we apoptosis in 48 h by milder BCR ligation using soluble antiintroduced an expression construct for the cowpox virus Ig antibody (11) in agreement with the observations from serpin CrmA, a potent inhibitor of caspase-8 (35) , into the studies on autoantibody-transgenic mice. BCR ligationmouse B cell line WEHI-231, and demonstrated that CrmA induced apoptosis is abnormally reduced in NZB and blocks Fas-mediated but not BCR-mediated apoptosis. We (NZBϫNZW)F 1 mice, which are prone to systemic autoimmune further demonstrated that extensive BCR cross-linking by disease (7, 10) , and it is possible that this defect is involved immobilized anti-Ig antibody induced apoptosis in B cells in generation of self-reactive B cells and autoantibody from C57BL/6-lpr/lpr mice as efficiently as in B cells from production.
C57BL/6 mice. These results clearly indicated that Fas is Fas is essential for TCR ligation-induced apoptosis of dispensable for rapid BCR-mediated apoptosis. Moreover, mature T cells and T cell lines both in vivo and in vitro DR3, DR4, DR5 and DR6 also do not appear to be required for (12) (13) (14) (15) (16) (17) (18) (19) . Signaling through TCR up-regulates expression of BCR-mediated apoptosis as those death receptors also both Fas and Fas ligand (FasL), and causes Fas-mediated depend on CrmA-sensitive caspases for apoptosis. In conapoptosis by an autocrine mechanism. Fas has been reported trast, B cell apoptosis induced by immobilized anti-Ig to be required for apoptosis of B cells anergized by interaction antibodies was defective in both MRL-ϩ/ϩ and MRL-lpr/lpr with soluble antigens (20) . This suggests that mild BCR mice. The defect in BCR-mediated apoptosis of the MRL ligation induces Fas-mediated apoptosis at least in vivo, background, together with the lpr mutation, may play a role although it is not known whether this apoptosis is induced by in the development of severe autoimmune disease in MRLan autocrine pathway. In contrast, Kozono et al. (21) have lpr/lpr mice. demonstrated that treatment with soluble anti-Ig antibody for 24 h induces apoptosis normally in lpr B cells, indicating that Fas is not essential for apoptosis induced by mild BCR Methods ligation. However, this treatment induces apoptosis only in a small fraction of B cells (21) , whereas most of the B cells
Mice and cells exposed to soluble antigens in vivo are thought to slowly C57BL/6, C57BL/6-lpr/lpr, MRL-ϩ/ϩ and MRL-lpr/lpr mice undergo apoptosis by a Fas-dependent mechanism (20) .
were purchased from Sankyo Labo Service (Tokyo, Japan). Therefore, significance of the Fas-independent pathway for Small dense B cells were purified from mouse spleens as apoptosis induced by mild BCR ligation is not yet clear.
described previously (10) . WEHI-231.5 is a subclone of Moreover, it has also not yet been elucidated whether Fas is WEHI-231 obtained in our laboratory (36). essential for B cell apoptosis induced by strong BCR ligation.
MRL-lpr/lpr mice carry a loss-of-function mutation of the Plasmids and transfection Fas gene (lpr mutation) (22) . These mice develop lymphadenopathy and a severe systemic lupus erythematosus For construction of the expression plasmid for the FLAG-(SLE)-like autoimmune disease, characterized by production tagged dominant negative form of FADD (FADD-DN), a BglII of autoantibodies to nuclear antigens (23, 24) . Development fragment containing cDNA for FLAG-tagged human FADD of the severe autoimmune disease requires both the lpr lacking the N-terminal 79 amino acids was isolated from pEFmutation and unknown defects in the MRL background FLAGFADD-DN79-pGKpuro (34) . After blunting both ends, because the lpr mutation causes lymphadenopathy but not the fragment was subcloned into EcoRI-XhoI-opened bluntended pMKITNeo (a gift of Dr Maruyama), resulting in pMKIT-SLE-like autoimmunity on different genetic backgrounds such FADD-DN. The expression plasmid pMKITCrmA coding for WEHI-231 cells and its transfectants were incubated with biotin-labeled anti-mouse Fas mAb Jo-2 (PharMingen) in FLAG-tagged CrmA was constructed by blunting the ends of a KpnI fragment of pEF-FLAGcrmA-pGKpuro (37) followed by the presence of anti-Fcγ receptor antibody 2.4G2, followed by incubation with FITC-labeled streptavidin (Dako, Carpinteria, subcloning into EcoRI-XhoI-opened blunt-ended pMKITNeo. Transfection of WEHI231.5 with the expression plasmids was CA). Alternatively, WEHI-231 cells and its transfectants were incubated with FITC-conjugated anti-mouse IgM antibody done as described previously (36). For construction of an expression vector for human bcl-2 (pMIK-bcl2), pMIKneo (Southern Biotechnology). For detection of cells containing hypodiploid nuclei, cells were incubated in PBS containing (-XbaI) was generated by digestion of the pMIKneo vector (a gift of Dr. Maruyama) with XbaI, followed by self-ligation. The 0.15 % Triton X-100 and 5 µg/ml of RNase, followed by staining with 50 µg/ml of propidium iodide. For cell cycle EcoRI fragment of the plasmid Bcl-2#58 (a gift of Dr Seto) (38) containing full-length human bcl-2 was inserted into the analysis, cells were incubated with 20 µM of BrdU (Sigma, St Louis, MO) at 37°C for 10 min. Cells were collected, fixed EcoRI-opened pMIKneo(-XbaI).
with 70% ethanol and treated with 4 N HCl containing 0.5%
Cell culture
Triton X-100 at room temperature for 20 min. After washing, cells were suspended in PBS containing 1% BSA and Plastic-immobilized anti-Ig antibody was prepared by incubating PBS containing 20 µg/ml of F(abЈ) 2 fragments of 10 µg/ml propidium iodide. Cells were analyzed by flow cytometry using a FACSCalibur (Becton Dickinson, San affinity-purified goat anti-mouse IgM antibody (ICN, Aurora, OH) in wells of plastic dishes at 37°C overnight, followed by Jose, CA). washing with PBS. Small dense B cells were cultured in RPMI 1640 medium supplemented with 10% FCS, 50 µM Results 2-mercaptoethanol and 2 mM L-glutamine with immobilized anti-Ig antibody, 1 µg/ml anti-mouse CD40 mAb HM40-3 (a BCR-mediated apoptosis of WEHI-231 cells requires neither gift of Dr Yagita) or both. Cells (1.0ϫ10 4 ) of WEHI-231. 5 FADD nor CrmA-sensitive caspases and its transfectants were cultured in 100 µl of medium with 10 µg/ml of anti-mouse CD40 mAb HM40-3 for 24 h and To investigate whether Fas signaling is involved in BCRmediated apoptosis of the mouse B cell line WEHI-231, then cultured with 10 µg/ml of anti-mouse Fas mAb Jo-2 (PharMingen, San Diego, CA). Alternatively, cells were we transfected WEHI-231.5 cells with expression vectors encoding either a dominant negative form of FADD (FADDcultured in 100 µL of medium with 10 µg/ml of F(abЈ) 2 fragments of goat anti-mouse IgM antibody (ICN) for 24 or DN) or the cowpox virus serpin CrmA. Since both FADD-DN and CrmA are tagged with FLAG, expression of FADD-DN 48 h.
and CrmA was confirmed in transfectants by Western blot Cell stimulation and Western blotting analysis using anti-FLAG mAb ( Fig. 1A and B). WEHI-231.5 cells expressed a small amount of Fas on the surface and its Small dense B cells were treated with 20 µg/ml of F(abЈ) 2 fragments of goat anti-mouse IgM antibody (ICN) for at 37°C expression was slightly increased by treatment with anti-CD40 mAb (Fig. 1C ). Both the FADD-DN transfectants and and lysed in SDS sample buffer. Cell lysates were separated by SDS-PAGE. Proteins were transferred to PVDF membrane CrmA transfectants showed the levels of Fas expression similar to the parent WEHI-231.5, regardless of the presence (Amersham Pharmacia Biotech, Piscataway, NJ), and reacted with either peroxidase-conjugated anti-phosphotyrosine mAb or absence of anti-CD40 mAb. Untreated WEHI-231.5 did not undergo apoptosis by treatment with anti-Fas mAb Jo-2 (data 4G10 (Upstate Biotechnology, Lake Placid, NY), the combination of rabbit anti-phospho-p42/p44 MAP kinase antibody not shown). However, when pretreated with anti-CD40 mAb for 24 h,~50% of the WEHI-231.5 cells died upon stimulation (New England Biolabs, Beverly, MA) and peroxidaseconjugated anti-rabbit IgG antibody (New England Biolabs), with anti-Fas mAb (Fig. 1D ). This is consistent with previous studies which showed that CD40 signaling enhances Fasor the combination of rabbit anti-ERK2 antibody (Santa Cruz Biotechnology, Santa Cruz, CA) and peroxidase-conjugated mediated apoptosis of B cells (40) (41) (42) (43) . In contrast, this treatment killed only a very small number of FADD-DN transanti-rabbit IgG antibody (Amersham, Little Chalfont, UK). WEHI-231 cells and its transfectants were lysed in phosphofectants and CrmA transfectants. These results demonstrate that expression of either FADD-DN or CrmA blocks Faslysis buffer (39) , and 50 µg of lysates was subjected to 13% SDS-PAGE. Proteins were transferred to PVDF mediated apoptosis in WEHI-231 cells. Both WEHI-231.5 FADD-DN transfectants and WEHI-231.5 membrane (Amersham Pharmacia Biotech) and incubated with 10 µg/ml of anti-FLAG-M2 mAb (Eastman Kodak, New
CrmA transfectants expressed similar levels of surface IgM to the parent WEHI-231.5 ( Fig. 2A ). Upon treatment with Haven, Connecticut), followed by reaction with horseradish peroxidase-labeled anti-mouse IgG antibody (Southern Bio-10 µg/ml of polyclonal anti-IgM antibody for 48 h, both WEHI-231.5 FADD-DN transfectants and WEHI-231.5 CrmA technology Associates, Birmingham, AL). Proteins were detected using the ECL Western system (Amersham transfectants died as efficiently as parental WEHI-231.5 cells (Fig. 2B) . Moreover, these transfectants showed a similar Pharmacia Biotech).
increase in the percentage of cells with hypodiploid nuclei, Flow cytometry characteristic for apoptosis, as did parental WEHI-231.5 cells (Fig. 2C) . These results indicate that BCR ligation induces Small dense B cells were stained with FITC-labeled antimouse CD3 mAb (PharMingen) and phycoerythrin (PE)-apoptosis in both WEHI-231.5 FADD-DN transfectants and WEHI-231.5 CrmA transfectants as efficiently as in parental labeled anti-mouse IgM antibody (Southern Biotechnology). (WEHI-bcl2) and WEHI-231.5 were cultured with anti-IgM antibodies, cell death of WEHI-bcl2 was markedly reduced compared to that of WEHI-231.5 cells (Fig. 3A) , although they expressed similar levels of BCR (data not shown). In WEHI-231.5 cells. Taken together, the adapter FADD and CrmA-sensitive caspases are essential for Fas-mediated but contrast, treatment with the anti-Fas mAb Jo-2-induced cell death in WEHI-bcl2 cells as efficiently as in WEHI-231.5 cells not BCR-mediated apoptosis in WEHI-231.
Bcl-2 and its homologues inhibit many cell death path- (Fig. 3B ). These results demonstrate that Bcl-2 can block BCR-mediated but not Fas-mediated apoptosis of WEHI-231 ways, but are poor antidotes to apoptosis induced by 'death receptors' such as Fas (37). We therefore studied the effects cells. This underscores that BCR ligation induces apoptosis in WEHI-231 cells by a signaling pathway that is distinct from of Bcl-2 on apoptosis of WEHI-231 induced by either Fas or BCR ligation. When WEHI-231 transfected with human bcl-2 that activated by Fas ligation. 
BCR-mediated death is defective in MRL mice
Previously, Kozono et al. demonstrated that treatment with soluble anti-IgM antibody induces rapid apoptosis in a we purified splenic B cells from 8-to 12-week-old C57BL/6 and C57BL/6-lpr/lpr mice, and cultured them in plastic wells containing immobilized anti-IgM antibody or in medium alone. After 24 or 48 h, we collected the cells, and measured the This result indicated that BCR-mediated death is defective in both MRL-ϩ/ϩ and MRL-lpr/lpr B cells, and suggested that percentages of live and dead cells by Trypan blue exclusion. Treatment with anti-IgM antibody significantly increased the the MRL background carries a defect in BCR-mediated apoptosis. percentage of dead cells in both C57BL/6 and C57BL/6-lpr/ lpr B cells at both 24 and 48 h, and no significant difference Finally, we assessed whether MRL B cells have defects in expression or signaling function of BCR. However, surface was observed between normal and lpr mutant cells (Fig. 4) . This result demonstrates that Fas is not required for BCR expression of IgM on CD3 -spleen cells of both MRL-ϩ/ϩ and MRL-lpr/lpr mice was comparable to that of C57BL/ ligation-induced apoptosis of normal splenic B cells.
Next, we tested the impact of BCR ligation on B cells from 6 and C57BL/6-lpr/lpr mice (Fig. 6A) , indicating that BCR expression is not defective in MRL B cells. Moreover, treat-MRL-ϩ/ϩ and MRL-lpr/lpr mice. As a control, we used spleen B cells of C57BL/6 mice. Although treatment with immobilized ment with anti-IgM antibody induces a similar level of phosphorylation of various cellular substrates including ERK anti-IgM antibody for 24 h markedly enhanced the killing of C57BL/6 B cells, the same treatment increased the percentin B cells of MRL-ϩ/ϩ mice or C57BL/6 mice ( Fig. 6B and C), indicating that MRL B cells do not carry a generalized age of dead cells in both MRL-ϩ/ϩ and MRL-lpr/lpr B cells only marginally (Fig. 5) . Moreover, the percentage of dead defect in BCR signaling. To further assess whether MRL B cells carry a defect in stimulatory signaling by extensive BCR cells was significantly reduced in MRL B cells comparing to C57BL/6 mice by prolonged treatment with anti-Ig for 48 h.
ligation, we tested cell cycle entry of B cells cultured with or without immobilized anti-IgM antibody. Since immobilized anti-MRL B cells appear to have a specific defect in an apoptotic signaling pathway activated by extensive BCR ligation. IgM antibody induces death of almost all the C57BL/6 B cells, we blocked B cell apoptosis by treatment with anti-CD40 antibody. Treatment with anti-CD40 antibody alone induced Discussion cell cycle entry to the S phase only a small fraction of B cells (Fig. 7) . However, treatment with immobilized anti-IgM
We demonstrate that WEHI-231 cells expressing either FADD-DN or CrmA undergo apoptosis in 48 h by BCR ligation but together with anti-CD40 efficiently induced cell cycle entry in both MRL-ϩ/ϩ and C57BL/6 B cells. This result indicated no longer die by Fas ligation, whereas a sizable fraction of WEHI-231 are killed by anti-Fas antibody. This indicates that that treatment with anti-CD40 antibody alone is not sufficient for efficient cell cycle entry of B cells, and that extensive BCR expression of either FADD-DN or CrmA blocks Fas-mediated but not BCR-mediated apoptosis of WEHI-231 cells. Since ligation by immobilized anti-Ig antibody induces cell cycle entry of anti-CD40-stimulated B cells of both MRL and C57BL/ FADD appears to play a role in cell proliferation as well as apoptotic signaling (33, 34) , FADD-DN might inhibit signaling 6 mice. Therefore, the stimulatory effect of extensive BCR ligation on cell cycle entry was not defective in MRL B cells.
for B cell growth and survival as well as Fas signaling. However, CrmA blocks Fas-induced apoptosis by inactivating In culture, extensive BCR cross-linking induces apoptosis within 48 h in normal B cells (10, 11) . In contrast, soluble caspase-8 and has no influence on cell proliferation (35, 37, 44) . Since expression of CrmA also fails to block BCRanti-Ig antibodies that mildly ligate BCR do not induce apoptosis within 48 h in most B cells, but may induce apoptosis mediated apoptosis in WEHI-231, Fas signaling appears dispensable for this process. This is in agreement with the more slowly. Indeed, interaction with soluble antigens, which ligate BCR mildly, induces B cell apoptosis within mice over previous finding by Kozono et al. that mild BCR ligation induces apoptosis of B cells in 24 h in both C57BL/6 and the course of several days (4). It is not possible to reproduce this process in culture because a substantial fraction of normal C57BL/6-lpr/lpr mice, carrying a mutation in Fas, although this treatment kills only a small fraction of B cells (21) .
B cells die even in the absence of BCR ligation within 48 h. B cell apoptosis induced by soluble antigens within mice has Apoptosis by extensive BCR ligation is more efficient than that induced by mild BCR ligation (7) (8) (9) (10) (11) , suggesting that been shown to require Fas (20) , whereas our data presented here demonstrate that Fas is not essential for apoptosis extensive BCR ligation generates a distinct apoptotic signaling from that induced by mild BCR ligation. However, our results induced by immobilized anti-Ig antibody. Extensive BCR ligation may thus be required for activation of Fas-independent demonstrate that extensive BCR ligation induces death of B cells of C57BL/6-lpr/lpr mice as efficiently as in normal apoptosis. This is in agreement with the finding that Fas is not essential for clonal deletion of self-reactive B cells by C57BL/6 B cells. Fas is thus dispensable in BCR-mediated occurring rapidly within 48 h in both normal B cells and WEHImembrane-bound antigens that cross-link BCR extensively (45) . Taken together, BCR ligation appears to activate both 231. Related death receptors also appear to be dispensable for BCR ligation-induced cell killing because apoptosis of Fas-dependent and -independent pathways to apoptosis. The Fas-dependent apoptosis takes several days, whereas the BCR-ligated WEHI-231 is not inhibited by CrmA, which blocks pro-apoptotic activity of Fas-related death receptors.
Fas-independent apoptosis is rapid but requires strong BCR ligation. This is in contrast to TCR ligation-induced apoptosis severe autoimmune disease in MRL-lpr/lpr mice. We demonstrate here that the MRL background carries a Fasof mature T cells, which requires Fas in culture and within mice (12) (13) (14) (15) (16) (17) (18) (19) . In both T and B cells, antigen receptor signaling independent defect in BCR-mediated apoptosis. Since MRL B cells show normal expression of BCR, normal phosphorylacan activate Fas-dependent apoptosis by up-regulating expression of Fas and FasL (12) (13) (14) (15) (16) (17) (18) (19) 46) . However, mature B tion of cellular substrates upon BCR ligation (Fig. 6) and normal response to a proliferation-inducing signal generated cells differ from mature T cells in that mature B cells but not mature T cells are capable of activating Fas-independent by extensive BCR ligation (Fig. 7) , they carry a restricted defect in apoptotic signaling but not a general defect in BCR apoptosis by antigen receptor ligation.
Since BCR ligation induces rapid apoptosis of WEHI-231 signaling. This defect may be involved in development of autoimmune disease by allowing the survival of self-reactive cells independently of Fas signaling, BCR-mediated apoptosis of WEHI-231 may be a useful tool to analyze the Fas-B cells even in the presence of self-antigens. It is possible that the MRL background carries additional defects which independent pathway of BCR-mediated apoptosis. Recent studies have identified members of the TNF receptor family promote development of autoimmune disease. As discussed above, apoptosis induced by antigen receptor ligation can that can transmit apoptotic signals (e.g. DR3, DR4, DR5 and DR6) (29, 31, (47) (48) (49) . Since many of these receptors involve both Fas-dependent and -independent pathways. The Fas-independent defect in BCR-mediated apoptosis in the are expressed in lymphocytes, they might be involved in lymphocyte apoptosis (47) . However, BCR-mediated MRL background may thus synergize with the defect in Fas (lpr mutation), resulting in severe defects in antigen-induced apoptosis of WEHI-231 is not inhibited by expression of CrmA (Fig. 2) , which blocks apoptosis mediated by Fas, deletion of self-reactive B cells.
We and others have previously demonstrated that BCR-DR3, DR4, DR5 and DR6, most likely by inhibiting caspase-8 (29, 47) . Since Fas-mediated apoptosis is blocked in WEHImediated apoptosis is defective in NZB and (NZBϫNZW)F 1 mice, which are also prone to systemic autoimmune disease, 231 CrmA transfectants, expression of CrmA is sufficient for inhibiting apoptosis mediated by Fas, and probably DR3, although these studies assessed only the rapid BCR ligationinduced apoptosis, which is independent of Fas (7,10,21). DR4, DR5 and DR6. Therefore, BCR-mediated apoptosis of WEHI-231 does not involve members of the TNF receptor Moreover, autoimmune disease-prone BXSB mice (58) and patients with SLE (59, 60) overexpress CD40 ligand on family that have a death domain.
We demonstrate here that Bcl-2 blocks BCR-mediated lymphocytes. Since CD40 signaling blocks BCR-mediated apoptosis (8) (9) (10) (11) 61, 62) , BXSB mice and patients with SLE but not Fas-induced apoptosis in WEHI-231 cells. This finding is consistent with the notion that Fas-mediated may also have a defect in BCR-mediated apoptosis. Since BCR-mediated apoptosis is reduced in multiple independent apoptosis is distinct from Bcl-2-regulated apoptosis at least in lymphoid cells (37,50). Bcl-2-regulated apoptosis is mouse lines prone to systemic autoimmune diseases and is thought to be abnormal in SLE patients, this defect may play accompanied by mitochondrial dysfunction, resulting in release of pro-apoptotic factors from mitochondria such as an important role in the pathogenesis of systemic autoimmune diseases. cytochrome c. Cytochrome c can interact with the adapter protein Apaf-1 and activate caspase-9, which then processes caspase-3. Bcl-2 and its homologs such as Bcl-x L preventhepatocytes, however, Fas has been reported to induce apoptosis via mitochondrial dysfunction (56 
